학술논문


EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
전자자료 공정이용 안내

우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.

공정이용 지침
  • 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
  • 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
  • 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
  • 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
  • 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
  • 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
  • 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
  • 상업적·영리적 목적으로 자료를 전송·복제·활용
  • ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
  • EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
  • 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
  • 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
  • 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문' 에서 검색결과 199건 | 목록 1~20
Academic Journal
Cortes J; International Breast Cancer Center (IBCC), Pangaea Oncology, Quironsalud Group, and IOB Madrid, Hospital Beata Maria Ana, and Universidad Europea de Madrid, Faculty of Biomedical and Health Sciences, Department of Medicine, Madrid, Spain. jacortes@vhio.net.; Lipatov O; Republican Clinical Oncology Dispensary, Republic of Bashkortostan, Ufa, Russian Federation.; Im SA; Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea.; Goncalves A; Aix Marseille University, CNRS, INSERM, Medical Oncology Department, Institut Paoli-Calmettes, CRCM, Marseille, France.; Lee KS; Center for Breast Cancer, National Cancer Center, Goyang, Republic of Korea.; Schmid P; Centre for Experimental Cancer Medicine, Barts Cancer Institute, Queen Mary University London, London, UK.; Tamura K; National Cancer Center Hospital, Tokyo, Japan.; Testa L; Instituto do Câncer do Estado de São Paulo, Faculdade de Medicina da Universidade do Estado do São Paulo, São Paulo, Brazil.; Ohtani S; Hiroshima City Hiroshima Citizens Hospital, Hiroshima, Japan.; Harbeck N; Breast Center, Department of Obstetrics and Gynecology and CCC Munich, Ludwig-Maximilians University, Munich, Germany.; Loi S; Division of Cancer Research, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; The Sir Peter MacCallum Department of Medical Oncology, The University of Melbourne, Parkville, VIC, Australia.; Salgado R; Division of Cancer Research, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Department of Pathology, ZAS Hospitals, Antwerp, Belgium.; Karantza V; Merck & Co., Inc., Rahway, NJ, USA.; Mejia J; Merck & Co., Inc., Rahway, NJ, USA.; Cristescu R; Merck & Co., Inc., Rahway, NJ, USA.; Loboda A; Merck & Co., Inc., Rahway, NJ, USA.; Nebozhyn M; Merck & Co., Inc., Rahway, NJ, USA.; Jelinic P; Merck & Co., Inc., Rahway, NJ, USA.; Huang L; Merck & Co., Inc., Rahway, NJ, USA.; Winer EP; Yale Cancer Center, New Haven, CT, USA.
Publisher: Breast Cancer Research Foundation Country of Publication: United States NLM ID: 101674891 Publication Model: Electronic Cited Medium: Print ISSN: 2374-4677 (Print) Linking ISSN: 23744677 NLM ISO Abbreviation: NPJ Breast Cancer Subsets: PubMed not MEDLINE
Academic Journal
Ledermann JA; Department of Oncology, UCL Cancer Institute, University College London, London, United Kingdom. Electronic address: j.ledermann@ucl.ac.uk.; Shapira-Frommer R; The Ella Lemelbaum Institute for Immuno-Oncology, Sheba Medical Center, Tel HaShomer Hospital, Ramat Gan, Israel.; Santin AD; Department of Obstetrics, Gynecology, and Reproductive Sciences, Yale University, New Haven, CT, United States.; Lisyanskaya AS; Department of Oncogynecology, St. Petersburg City Clinical Oncology Dispensary, St. Petersburg, Russia.; Pignata S; Department of Urology and Gynecology, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Naples, Italy.; Vergote I; Department of Obstetrics and Gynaecology, Division of Gynecologic Oncology, University Hospital Leuven, Leuven, Belgium.; Raspagliesi F; Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; Sonke GS; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands.; Birrer M; UAMS Winthrop P. Rockefeller Cancer Institute, Little Rock, AR, United States.; Provencher DM; Centre Hospitalier de l'Université de Montréal (CHUM), Institut du Cancer de Montréal, Montreal, Canada.; Sehouli J; Gynecology with Center of Oncological Surgery, Charité-Medical University of Berlin, Berlin, Germany.; Colombo N; Department of Medicine and Surgery, University of Milan-Bicocca, Milan, Italy; European Institute of Oncology, IRCCS, Milan, Italy.; González-Martín A; Department of Medical Oncology and Program in Solid Tumors-Cima, Cancer Center Clínica Universidad de Navarra, Madrid, Spain.; Oaknin A; Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Ottevanger PB; Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands.; Rudaitis V; Clinic of Obstetrics and Gynecology, Vilnius University Institute of Clinical Medicine, Vilnius, Lithuania.; Kobie J; Merck & Co., Inc., Rahway, NJ, United States.; Nebozhyn M; Merck & Co., Inc., Rahway, NJ, United States.; Edmondson M; Merck & Co., Inc., Rahway, NJ, United States.; Sun Y; Merck & Co., Inc., Rahway, NJ, United States.; Cristescu R; Merck & Co., Inc., Rahway, NJ, United States.; Jelinic P; Merck & Co., Inc., Rahway, NJ, United States.; Keefe SM; Merck & Co., Inc., Rahway, NJ, United States.; Matulonis UA; Division of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.
Publisher: Academic Press Country of Publication: United States NLM ID: 0365304 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-6859 (Electronic) Linking ISSN: 00908258 NLM ISO Abbreviation: Gynecol Oncol Subsets: MEDLINE
Academic Journal
Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101705370 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2473-4284 (Electronic) Linking ISSN: 24734284 NLM ISO Abbreviation: JCO Precis Oncol Subsets: PubMed not MEDLINE; MEDLINE
Academic Journal
Janjigian YY; Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY.; Cecchini M; Yale School of Medicine, New Haven, CT.; Shitara K; National Cancer Center Hospital East, Kashiwa, Japan.; Enzinger PC; Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA.; Wainberg ZA; David Geffen School of Medicine at UCLA, Los Angeles, CA.; Chau I; The Royal Marsden NHS Foundation Trust, The Royal Marsden-Sutton, Surrey, United Kingdom.; Satoh T; Osaka University Graduate School of Medicine, Osaka, Japan.; Lee J; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.; Nebozhyn M; Merck & Co, Inc, Rahway, NJ.; Loboda A; Merck & Co, Inc, Rahway, NJ.; Kobie J; Merck & Co, Inc, Rahway, NJ.; Vajdi A; Merck & Co, Inc, Rahway, NJ.; Shih CS; Merck & Co, Inc, Rahway, NJ.; Cristescu R; Merck & Co, Inc, Rahway, NJ.; Cao ZA; Merck & Co, Inc, Rahway, NJ.
Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101705370 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2473-4284 (Electronic) Linking ISSN: 24734284 NLM ISO Abbreviation: JCO Precis Oncol Subsets: MEDLINE
Academic Journal
Shitara K; Department of Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan kshitara@east.ncc.go.jp.; Department of Immunology, Nagoya University Graduate School of Medicine, Nagoya, Japan.; Di Bartolomeo M; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; Mandala M; Unit of Medical Oncology, University of Perugia, Perugia, Italy.; Ryu MH; Department of Oncology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea (the Republic of).; Caglevic C; Cancer Research Department, Instituto Oncologico Fundacion Arturo Lopez Perez, Santiago, Chile.; Olesinski T; Department of Gastrointestinal Cancers and Neuroendocrine Tumors Surgery, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.; Chung HC; Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea (the Republic of).; Muro K; Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan.; Goekkurt E; Hematology-Oncology Practice Eppendorf (HOPE) and University Cancer Center Hamburg (UCCH), University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; McDermott RS; St Vincent's University Hospital & Cancer Trials, Dublin, Ireland.; Mansoor W; Christie Hospital NHS Foundation Trust, University of Manchester, Manchester, UK.; Wainberg ZA; Division of Hematology/Oncology, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.; Shih CS; Merck & Co Inc, Rahway, New Jersey, USA.; Kobie J; Merck & Co Inc, Rahway, New Jersey, USA.; Nebozhyn M; Merck & Co Inc, Rahway, New Jersey, USA.; Cristescu R; Merck & Co Inc, Rahway, New Jersey, USA.; Cao ZA; Merck & Co Inc, Rahway, New Jersey, USA.; Loboda A; Merck & Co Inc, Rahway, New Jersey, USA.; Özgüroğlu M; Division of Medical Oncology, Clinical Trial Unit, Istanbul University-Cerrahpaşa, Cerrahpaşa Faculty of Medicine, Istanbul, Turkey.
Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Print Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE
Academic Journal
Xiang H; Discovery Immunology, Merck & Co., Inc., Cambridge, Massachusetts.; Pan Y; Data and Genome Sciences, Merck & Co., Inc., Boston, Massachusetts.; Sze MA; Data and Genome Sciences, Merck & Co., Inc., Boston, Massachusetts.; Wlodarska M; Discovery Oncology, Merck & Co., Inc., Boston, Massachusetts.; Li L; Quantitative Bioscience, MSD, Singapore.; van de Mark KA; Discovery Immunology, Merck & Co., Inc., Cambridge, Massachusetts.; Qamar H; Discovery Immunology, Merck & Co., Inc., Cambridge, Massachusetts.; Moure CJ; Discovery Oncology, Merck & Co., Inc., Boston, Massachusetts.; Linn DE; Quantitative Bioscience, Merck & Co., Inc., Boston, Massachusetts.; Hai J; Quantitative Bioscience, Merck & Co., Inc., Boston, Massachusetts.; Huo Y; Quantitative Bioscience, Merck & Co., Inc., Boston, Massachusetts.; Clarke J; Data and Genome Sciences, Merck & Co., Inc., Boston, Massachusetts.; Tan TG; Discovery Cardiometabolic Diseases, MSD, Singapore.; Ho S; Discovery Cardiometabolic Diseases, MSD, Singapore.; Teng KW; Discovery Cardiometabolic Diseases, MSD, Singapore.; Ramli MN; Quantitative Bioscience, MSD, Singapore.; Nebozhyn M; Data and Genome Sciences, Merck & Co., Inc., Boston, Massachusetts.; Zhang C; Data and Genome Sciences, Merck & Co., Inc., Boston, Massachusetts.; Barlow J; The Division of Thoracic Surgery, Brigham & Women's Hospital, Harvard Medical School, Boston, Massachusetts.; Gustafson CE; The Division of Thoracic Surgery, Brigham & Women's Hospital, Harvard Medical School, Boston, Massachusetts.; Gornisiewicz S; The Division of Thoracic Surgery, Brigham & Women's Hospital, Harvard Medical School, Boston, Massachusetts.; Albertson TP; The Division of Thoracic Surgery, Brigham & Women's Hospital, Harvard Medical School, Boston, Massachusetts.; Korle SL; The Division of Thoracic Surgery, Brigham & Women's Hospital, Harvard Medical School, Boston, Massachusetts.; Bueno R; The Division of Thoracic Surgery, Brigham & Women's Hospital, Harvard Medical School, Boston, Massachusetts.; Moy LY; Quantitative Bioscience, Merck & Co., Inc., Boston, Massachusetts.; Vollmann EH; Discovery Immunology, Merck & Co., Inc., Cambridge, Massachusetts.; Chiang DY; Data and Genome Sciences, Merck & Co., Inc., Boston, Massachusetts.; Brandish PE; Discovery Oncology, Merck & Co., Inc., Boston, Massachusetts.; Loboda A; Data and Genome Sciences, Merck & Co., Inc., Boston, Massachusetts.
Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 2984705R Publication Model: Print Cited Medium: Internet ISSN: 1538-7445 (Electronic) Linking ISSN: 00085472 NLM ISO Abbreviation: Cancer Res Subsets: MEDLINE
Patent
Patent
검색 결과 제한하기
제한된 항목
[검색어] Nebozhyn M
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어